Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-25-071556
Filing Date
2025-05-14
Accepted
2025-05-14 16:48:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 aktx-20250514.htm 424B3 777971
  Complete submission text file 0000950170-25-071556.txt   779167
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 424B3 | Act: 33 | File No.: 333-287012 | Film No.: 25946665
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)